Bing

SEARCH HISTORY

Investors in Vertex Pharmaceuticals, Inc. (NASD: VRTX) saw new options begin trading today, for the August 14th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the VRTX
Forbes · 1 day ago
VRTX
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Trade-Ideas LLC identified Vertex Pharmaceuticals ( VRTX) as an unusual ...
The Street · 1 day ago
Vertex Pharmaceuticals
Vertex Pharmaceuticals (NASDAQ:VRTX) Director Joshua S. Boger sold 11,700 shares of Vertex Pharmaceuticals stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price …
sleekmoney.com · 4 hours ago
transaction
More from Bing News
In after-hours, the stock was up 4.76% at $1.76 ... Vertex Pharmaceuticals Inc.s (VRTX) ORKAMBI has received FDA approval for the treatment of cystic fibrosis in people ages 12 and older with two copies of the F508del mutation. It is estimated that ...
NASDAQ · 1 day ago
Vertex Pharmaceuticals (NASDAQ:VRTX) Director Joshua S. Boger sold 11,700 shares of Vertex Pharmaceuticals stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $125.60, for a total value of $1,469,520.00.
Ticker Report · 11 hours ago
[Reuters] – Vertex Pharmaceuticals Inc’s unique combination therapy for a rare lung disorder was given the green light by U.S. health regulators, extending the company’s reach to the most common form of genetic …
Jutia Group · 1 day ago
Vertex Pharmaceuticals (NASDAQ: VRTX) is circling in a holding pattern. But touchdown is going to be so spectacular that it'll be worth the wait. As long as there's no crash landing, of course. The crucial moment will …
Investopedia · 6/30/2015
Vertex
Vertex Pharmaceuticals Incorporated (VRTX) experienced unusually high volume on Jul. 02, as the stock gained 4.02% to a closing price of $131.26. The stock saw 3.65 million shares trade hands over the course of the day on 28,779 trades. Given that the ...
Equities · 18 hours ago
Vertex Pharmaceuticals Incorpo…
VRTX is now essentially a cystic fibrosis stock, but not long ago, its Incivek for hepatitis C was the most successful new drug product introduction ever. Now Incivek has been completely supplanted by Sovaldi, Harvoni and others, but the point is that ...
Seeking Alpha · 6/26/2015
Bluebird Bio Inc (BLUE): BLUE stock is down 3.9% today. Bio-Reference Laboratories (BRLI): BRLI stock is down 3.8% today. Vertex Pharmaceuticals Inc (VRTX): VRTX stock is down 3.8% today. Wright Medical Group (WMGI): WMGI stock is down 3.6% …
Investor Place · 6/29/2015
Healthcare Stocks

Vertex Pharmaceuticals

Company
Vertex Pharmaceuticals is an American Pharmaceutical company based in Boston, Massachusetts. Vertex was founded in 1989 by Joshu…
Vertex Pharmaceuticals is an American Pharmaceutical company based in Boston, Massachusetts. Vertex was founded in 1989 by Joshua Boger and Kevin J. Kinsella. Vertex was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Data from: Wikipedia · Freebase